Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions

Journal of Oral Pathology & Medicine

Volumn 21, Issue 9, 1992, Pages 404-408

  Warnakulasuriya, K A A S ^a   Johnson, N W ^a  

^a ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

Author keywords

Antioncogene; oncogenes; oral cancer; p53; precancer, oral

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; ONCOGENE; PRECANCER; SQUAMOUS CELL CARCINOMA;

CARCINOMA; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; FEMALE; GENE EXPRESSION; HUMAN; KERATOSIS; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGE; MOUTH MUCOSA; MOUTH NEOPLASMS; MUTATION; PRECANCEROUS CONDITIONS; PROTEIN P53; SUPPORT, NON-U.S. GOV'T;

EID: 0026490218     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1992.tb01028.x     Document Type: Article

References (35)

1. Mutations in the p53 gene occur in diverse human tumour types
2. p53 mutations in human cancers
3. Expression of the p53 protein during cell cycle of human peripheral blood lymphocytes
4. The role of p53 in normal control of cell proliferation
5. The p53 protooncogene can act as a suppressor of transformation
6. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas
7. p53: oncogene or anti‐oncogene
8. Expression of the nuclear oncogene p53 in colon tumours
9. p53 mutations in colorectal cancer
10. p53 expression in colorectal tumours
11. p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study
12. Maintenance of p53 alterations throughout breast cancer progression
13. p53 expression in breast cancer
14. Increased expression of mutant forms of p53 oncogene in primary lung cancer
15. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies
16. Frequent mutation of the p53 gene in human oesophageal cancer
17. Mutant p53‐: The commonest genetic abnormality in human cancer
18. Expression of p53 in premalignant and malignant squamous epithelium
19. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck
20. Isolation of human‐p53‐specific monoclonal antibodies and their use in the studies of human p53 expression
21. The cellular oncogene p53 can be activated by mutagenesis
22. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines
23. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form
24. Different tumour‐derived p53 mutants exhibit distinct biological activities
25. Asymmetric PCR‐based strategy for genetic analysis of the p53 tumor suppressor gene in cell lines and tumour tissues
26. Mutation and cancer: Statistical study of retinoblastoma
27. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus
28. T‐antigen is bound to host protein in SV40‐transformed cells
29. Genetic alterations during colorectal‐tumor development
30. A genetic model for colorectal tumorigenesis
31. Prognostic value of various molecular and cellular features in oral squamous cell carcinomas: a review
32. Advanced methods in the evaluation of premalignant lesions and carcinomas of the oral mucosa
33. Envoi: New knowledge concerning oral cancer and research priorities